During pandemics, such as the COVID-19 pandemic, it can be challenging to offer care to vulnerable populations, especially those experiencing alcohol withdrawal. CADTH conducted a Rapid Response on the clinical effectiveness of using gabapentin, phenobarbital, diazepam, or lorazepam to treat alcohol withdrawal. This report also searched for evidence-based guidelines for treating alcohol withdrawal in the emergency department, and evidence-based guidelines for providing addiction services to vulnerable populations experiencing alcohol withdrawal during a pandemic. While no guidelines were identified regarding managing alcohol withdrawal during a pandemic, literature was identified regarding pharmaceutical options for treating alcohol withdrawal. Guidelines for treating alcohol withdrawal in the emergency department were also identified.
Link to Report
Provide Feedback
Was this site helpful?
If you couldn’t find what you are looking for, please submit a request.